• Subscribe

    Webinars & Whitepapers →

    ▾
  • Xconomy National

  • Xperience
    Tech + Life
      • Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates
        Fetch Rewards Grabs $25M, Plans to Double Staff as Growth Accelerates
      • Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto
        Nuance Spinout Cerence Vies With Tech Giants in Voice-AI for Auto
      • Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?
        Can Ford’s Self-Driving Car Business Improve Austin’s Traffic Woes?
      • John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22
        John Halamka, Livongo Health & AI Progress at X·CON on Oct. 22
      • As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle
        As More Grocers Embrace Tech, Swiftly Snags $15M to Launch in Seattle
      View More in Xperience ›
  • EXOME
    Biotech + Health
      • Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk
        Amarin’s Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk
      • Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More
        Bio Roundup: Sarepta’s Approval, Merck M&A, Drug Price Bill & More
      • In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug
        In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug
      • miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
        miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
      • Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
        Amgen’s Osteoporosis Drug Wins European Nod, With a Heart Warning
      View More in EXOME ›
  • Our
    Regions
    • Boston ›
      • In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug
        In an About-Face, FDA Approves Second Sarepta Muscular Dystrophy Drug
      View More in Boston ›
    • Boulder/Denver ›
      • miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
        miRagen Restructures to Focus on Fibrosis, Inks $20M Stock Deal
      View More in Boulder/Denver ›
    • Detroit/Ann Arbor ›
      • Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
        Stryker Adds to Trauma & Extremities Biz With $4B Wright Medical Deal
      View More in Detroit/Ann Arbor ›
    • Indiana ›
      • Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test
        Eli Lilly Drug Acquired in Armo Deal Fails Pancreatic Cancer Test
      View More in Indiana ›
    • New York ›
      • Amarin's Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk
        Amarin's Fish-Oil Pill Wins FDA Nod to Cut Heart Attack, Stroke Risk
      View More in New York ›
    • Raleigh-Durham ›
      • Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%
        Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%
      View More in Raleigh-Durham ›
    • San Diego ›
      • Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy
        Aspen Neuro Bags $6.5M to Test Parkinson’s Disease Stem Cell Therapy
      View More in San Diego ›
    • San Francisco ›
      • BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs
        BridgeBio Pharma Onboards Eli Wallace to Lead Oncology Programs
      View More in San Francisco ›
    • Seattle ›
      • A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns
        A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns
      View More in Seattle ›
    • Texas ›
      • Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
        Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing
      View More in Texas ›
    • Wisconsin ›
      • AI Can Unlock Health Data's Potential, But Access Is Still Difficult
        AI Can Unlock Health Data's Potential, But Access Is Still Difficult
      View More in Wisconsin ›
  • Tech
    Channels
    • Agtech and Food›
      • Pure Vino Looks to Find Personalized Deals for Wine Aficionados
      View More in Agtech and Food ›
    • Cleantech›
        View More in Cleantech ›
      • Cybersecurity›
          View More in Cybersecurity ›
        • Education›
            View More in Education ›
          • EXOME: Biotech + Health›
            • Daré to Add Microchip-Based Birth Control to Women’s Health Portfolio
              Daré to Add Microchip-Based Birth Control to Women’s Health Portfolio
            View More in EXOME ›
          • Fintech›
              View More in Fintech ›
            • Healthtech›
              • AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
                AI Can Unlock Health Data’s Potential, But Access Is Still Difficult
              View More in Healthtech ›
            • Robotics and A.I.›
              • AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund
                AstraZeneca Chooses China for R&D and AI Centers, $1B Biotech Fund
              View More in Robotics and A.I. ›
            • Startups›
              • Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology
                Bayer and Dewpoint Ink Deal for Drugs R&D at New Frontier of Biology
              View More in Startups ›
            • Xperience: Tech + Life›
                View More in Xperience ›
            • Meet the
              Xconomists
              • Andy Liu

                Andy Liu

                Co-Founder, BuddyTV

              • Ben Elowitz

                Ben Elowitz

                Co-Founder and CEO, Wetpaint

              • Aaron Houghton

                Aaron Houghton

                CEO and co-founder of BoostSuite

              • Ann Marie Sastry

                Ann Marie Sastry

                Co-Founder, Sakti3

              • Meet All the Xconomists ›
              • Bill McKeon

                Bill McKeon

                Vice president, chief strategy and operating officer of the Texas Medical Center

              • Andy Ory

                Andy Ory

                Founder and CEO, Acme Packet

              • Gerry Hays

                Gerry Hays

                Serial Entrepreneur and Investor

              • David Broecker

                David Broecker

                President & CEO, Indiana Biosciences Research Institute

            • Our
              Events
              • All Xconomy Events › Boston Events ›
              • Boulder/Denver Events › Detroit/Ann Arbor Events ›
              • Indiana Events › New York Events ›
              • Raleigh-Durham Events ›San Diego Events ›
              • San Francisco Events ›Seattle Events ›
              • Texas Events › Wisconsin Events ›
            • Xpertise
              Watch + Learn

            “3d-biomatrix” Archives

            in
            Entry Author Date Location
            U-M Spinout 3D Biomatrix Secures U.S. Patent for Cell Culture Product Sarah Schmid Stevenson 01/06/15 Detroit Ann Arbor
            Ann Arbor’s 3D Biomatrix Clears Final Hurdle to Patent Sarah Schmid Stevenson 02/06/14 Detroit Ann Arbor
            Venture Funding in Detroit Down in Q1, Still Higher Than 2011 Sarah Schmid Stevenson 04/19/13 Detroit Ann Arbor
            3D Biomatrix Receives $740,000 New Financing VentureDeal 02/05/13 Detroit Ann Arbor
            What’s New With Loveland Technologies, Axonia, 3D Biomatrix? Sarah Schmid Stevenson 05/23/12 Detroit Ann Arbor
            3D Biomatrix Hopes To Break Into Drug Discovery Market With 3D Testing Devices Thomas Lee 07/07/11 Detroit Ann Arbor
            U-M adds more tenants to Venture Accelerator Thomas Lee 02/15/11 Detroit Ann Arbor
            Page 1 of 1

            Underwriters and Partners

            Xpertise: Watch + Learn
            • Digitizing 10 Life Sciences Paper Processes

              Sponsored · Whitepaper

              Digitizing 10 Life Sciences Paper Processes

              How to accelerate your life sciences business with every agreement

              DocuSign
            • Potency Assay Development for Cell and Gene Therapy Products

              Sponsored · Whitepaper

              Potency Assay Development for Cell and Gene Therapy Products

              Create well-controlled, biologically relevant test systems and validate them to support FDA approvals

              Absorption Systems
            • Robert Langer reveals secrets to early-stage biotech success

              From Our Partners · Special Report

              Robert Langer reveals secrets to early-stage biotech success

              Advice for funding and future transformational opportunities

            Connect with Xconomy

            • Xconomy on Facebook
            • Xconomy on Twitter
            • Xconomy on Linkedin
            • Xconomy on Google PLus
            • Xconomy Feeds

            Xconomy on Demand

            Did you miss something? Don't despair…

            Xconomy offers a number of ways to subscribe for free!

            Subscribe Now
            IDG Tech Network
            Protected by Carbonite
            Eventbrite - events made easy
            • Home
            • Privacy/DMCA
            • Security Disclosures
            • About
            • Contact Us
            • Archives
            • Advertise
            • Subscribe for Free

            Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit/Ann Arbor, San Francisco, New York, Raleigh-Durham, Boulder/Denver, Texas, Wisconsin, Indiana, and beyond.

            © 2007-2019, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

            Website development support from Andrew Koyfman with design support from Rob Hunter.